Stage: Seed, Series A (tickets €1–3M, high involvement)
Focus: B2B SaaS, AI, deeptech, digital health, revenue-generating startups with global potential.
Portfolio: Controlant (cold-chain monitoring), Meniga (fintech), Sidekick Health (digital therapeutics), Kaptio (travel tech), Data Dwell.
Updates: In 2024 Frumtak closed its 4th fund at $87M. In April 2025, led the €2M pre-seed for Optise (AI website insights).
Website: frumtak.is